Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
904.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (0.668%)
Market Cap: £491.87m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate Change

22 Jan 2025 15:48

RNS Number : 3399U
JPMorgan Claverhouse IT PLC
22 January 2025
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Tom Smethers as a Non-Executive Director of the Company with effect from 3rd February 2025.

 

Mr. Smethers is an experienced finance professional, with a strong background in the FMCG, retail, hospitality and aviation sectors. Mr. Smethers has led major transformation projects, handled multiple M&A processes, and has international experience across Europe, the Middle East, and Australia.

Mr. Smethers was previously a Non-Executive Director and Audit Committee Chair of Artemis Alpha Trust plc and is currently a trustee of the charity, Wings for Warriors. He is presently the Chief Financial Officer at Carlsberg Britvic plc and held senior positions at Costa Coffee, TUI Group, Jumeirah Group LLC, and easyJet plc.

 

Mr. Smethers is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

Mr. Smethers does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Smethers.

 

 

22nd January 2025

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDBRSDDGUD
Date   Source Headline
7th Jan 202611:25 amRNSNet Asset Value(s)
6th Jan 202610:37 amRNSNet Asset Value(s)
5th Jan 202611:16 amRNSGearing Announcement
5th Jan 202610:48 amRNSNet Asset Value(s)
2nd Jan 202611:55 amRNSClosed Period Announcement
2nd Jan 202611:36 amRNSNet Asset Value(s)
31st Dec 202510:55 amRNSNet Asset Value(s)
30th Dec 202511:05 amRNSNet Asset Value(s)
29th Dec 202512:21 pmRNSGearing announcement
29th Dec 202512:21 pmRNSGearing announcement
29th Dec 202512:03 pmRNSNet Asset Value(s)
24th Dec 202510:34 amRNSNet Asset Value(s)
23rd Dec 202510:55 amRNSNet Asset Value(s)
22nd Dec 202512:04 pmRNSGearing Announcement
22nd Dec 202512:04 pmRNSGearing Announcement
22nd Dec 202511:45 amRNSNet Asset Value(s)
19th Dec 202511:42 amRNSNet Asset Value(s)
19th Dec 20257:00 amRNS-RKepler Trust Intelligence: New Research
19th Dec 20257:00 amRNS-RKepler Trust Intelligence: New Research
18th Dec 202510:49 amRNSNet Asset Value(s)
17th Dec 202511:08 amRNSNet Asset Value(s)
16th Dec 202511:20 amRNSNet Asset Value(s)
15th Dec 202511:31 amRNSGearing Announcement
15th Dec 202510:49 amRNSNet Asset Value(s)
12th Dec 202512:00 pmRNSNet Asset Value(s)
11th Dec 202510:38 amRNSNet Asset Value(s)
10th Dec 20254:50 pmRNSTen Largest Investments
10th Dec 202510:36 amRNSNet Asset Value(s)
9th Dec 202511:06 amRNSNet Asset Value(s)
8th Dec 202511:17 amRNSGearing Announcement
8th Dec 202510:56 amRNSNet Asset Value(s)
5th Dec 202511:12 amRNSNet Asset Value(s)
4th Dec 202511:06 amRNSNet Asset Value(s)
3rd Dec 202510:37 amRNSNet Asset Value(s)
2nd Dec 202511:34 amRNSNet Asset Value(s)
1st Dec 202512:31 pmRNSGearing Announcement
1st Dec 202511:42 amRNSNet Asset Value(s)
1st Dec 202510:29 amRNSTotal Voting Rights
28th Nov 202511:12 amRNSNet Asset Value(s)
27th Nov 202511:11 amRNSNet Asset Value(s)
26th Nov 20254:55 pmRNSTransaction in Own Shares
26th Nov 202511:11 amRNSNet Asset Value(s)
25th Nov 20254:59 pmRNSTransaction in Own Shares
25th Nov 202511:06 amRNSNet Asset Value(s)
24th Nov 202512:40 pmRNSGearing Announcement
24th Nov 202510:31 amRNSNet Asset Value(s)
21st Nov 20255:20 pmRNSTransaction in Own Shares
21st Nov 202511:07 amRNSNet Asset Value(s)
20th Nov 202511:03 amRNSNet Asset Value(s)
20th Nov 20257:00 amRNS-RInvestor Webinar: 21st November, 2025 9:00 a.m.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.